DE69418334T2 - Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen - Google Patents

Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen

Info

Publication number
DE69418334T2
DE69418334T2 DE1994618334 DE69418334T DE69418334T2 DE 69418334 T2 DE69418334 T2 DE 69418334T2 DE 1994618334 DE1994618334 DE 1994618334 DE 69418334 T DE69418334 T DE 69418334T DE 69418334 T2 DE69418334 T2 DE 69418334T2
Authority
DE
Germany
Prior art keywords
substances
vesicles
encapsulated
high loading
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1994618334
Other languages
English (en)
Other versions
DE69418334D1 (de
Inventor
Yechezkel Barenholz
Israel Nur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opperbas Holding BV
Original Assignee
Opperbas Holding BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opperbas Holding BV filed Critical Opperbas Holding BV
Application granted granted Critical
Publication of DE69418334D1 publication Critical patent/DE69418334D1/de
Publication of DE69418334T2 publication Critical patent/DE69418334T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1994618334 1993-08-06 1994-07-08 Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen Expired - Lifetime DE69418334T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93112642 1993-08-06
PCT/EP1994/002243 WO1995004524A1 (en) 1993-08-06 1994-07-08 A method for high loading of vesicles with biopolymeric substances

Publications (2)

Publication Number Publication Date
DE69418334D1 DE69418334D1 (de) 1999-06-10
DE69418334T2 true DE69418334T2 (de) 2000-01-27

Family

ID=8213143

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1994618334 Expired - Lifetime DE69418334T2 (de) 1993-08-06 1994-07-08 Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen

Country Status (9)

Country Link
EP (2) EP0713388B1 (de)
JP (1) JPH09501169A (de)
AT (1) ATE179599T1 (de)
AU (1) AU7384994A (de)
CA (1) CA2168671C (de)
DE (1) DE69418334T2 (de)
ES (1) ES2131206T3 (de)
IL (1) IL110305A (de)
WO (1) WO1995004524A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003035A1 (en) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
EP0909164B1 (de) * 1996-05-10 2002-08-21 Yamanouchi Europe B.V. Instant vesikuläres produkt
US5919480A (en) * 1996-06-24 1999-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal influenza vaccine composition and method
US7384923B2 (en) 1999-05-14 2008-06-10 Lipoxen Technologies Limited Liposomes
WO1998010748A1 (en) * 1996-09-13 1998-03-19 The School Of Pharmacy Liposomes
CA2268740C (en) * 1996-11-06 2010-07-20 Sequenom, Inc. High density immobilization of nucleic acids
US6133436A (en) * 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6024925A (en) 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
EP1332000B1 (de) 2000-10-30 2012-06-20 Sequenom, Inc. Verfahren zur aufbringung von submikroliter fluid-volumina auf ein substrat
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
KR20050025306A (ko) * 2002-07-03 2005-03-14 애프톤 코포레이션 리포좀 백신
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
AU2006235507B2 (en) 2005-04-12 2012-08-30 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
WO2008127651A1 (en) 2007-04-13 2008-10-23 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
US20090180931A1 (en) 2007-09-17 2009-07-16 Sequenom, Inc. Integrated robotic sample transfer device
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
GB201417589D0 (en) 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations
WO2016125163A1 (en) 2015-02-04 2016-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES
GB201518170D0 (en) 2015-10-14 2015-11-25 Cantab Biopharmaceuticals Patents Ltd Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent
GB201518171D0 (en) 2015-10-14 2015-11-25 Cantab Biopharmaceuticals Patents Ltd Colloidal particles for topical administration with therapeutic agent
GB201518172D0 (en) 2015-10-14 2015-11-25 Cantab Biopharmaceuticals Patents Ltd Colloidal particles for use in medicine
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
GB202111757D0 (en) 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A
GB202111759D0 (en) 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles
GB202111758D0 (en) 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.
US4348384A (en) * 1980-10-17 1982-09-07 Dainippon Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration containing coagulation factor VIII or IX
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
GB2135647A (en) * 1983-02-15 1984-09-05 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US4873035A (en) * 1987-11-25 1989-10-10 Abbott Laboratories Preparation of sized populations of liposomes

Also Published As

Publication number Publication date
EP0713388B1 (de) 1999-05-06
JPH09501169A (ja) 1997-02-04
ES2131206T3 (es) 1999-07-16
AU7384994A (en) 1995-02-28
EP0713388A1 (de) 1996-05-29
IL110305A (en) 1998-12-06
CA2168671A1 (en) 1995-02-16
WO1995004524A1 (en) 1995-02-16
ATE179599T1 (de) 1999-05-15
DE69418334D1 (de) 1999-06-10
EP0815852A1 (de) 1998-01-07
CA2168671C (en) 2007-04-10
IL110305A0 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
DE69418334D1 (de) Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
GR920100323A (el) Μία μέ?οδος παρασκευής μικροσφαιρίων αποτελούμενων από ένα βιοαποικοδομούμενο πολυμερικό υλικό.
US20080242820A1 (en) Molecular imprinting of small particles, and production of small particles from solid state reactants
WO1998043927A3 (en) Porous ceramic articles and method for the manufacture thereof
DK0869774T3 (da) Fremgangsmåde til fremstilling af vedvarende frigivende partikler
DE69714448D1 (de) Verfahren zur herstellung von präparaten mit kontrollierter wirkstofffreisetzung auf basis von polymeren
ATE255911T1 (de) Verfahren zur herstellung von mikrokapseln
ATE290405T1 (de) Verfahren zur herstellung von diagnostica
DE3784534D1 (de) Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinoidpraeparaten.
KR920003962A (ko) 서방형 제제 및 그의 제조 방법
ES2084712T3 (es) Metodo para producir microesferas proteicas.
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
ATE175132T1 (de) Verfahren zur herstellung von mikrokapseln
DE3382587D1 (de) Injizierbares langwirkendes mikroteilchen-praeparat zur verabreichung entzuendungshemmender mittel.
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
WO1992010514A3 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
EP1248150A3 (de) Strahlungsempfindliches Material und Verfahren zur Herstellung eines Musters
DE68901771D1 (de) Phospholipid enthaltende zusammensetzung, verfahren zu deren herstellung und verwendung als hilfsstoff fuer pharmazeutische substanzen.
ATE340639T1 (de) Verfahren zur herstellung von teilchen
CN103962074A (zh) 一种中空亚微米球、其制备方法与应用
ATE117003T1 (de) Verfahren zur herstellung von feinteiligen und porösen celluloseteilchen.
DE3776348D1 (de) Verfahren zur herstellung von produkten mit kontrollierter freigabe fuer kaugummi.
ATE66834T1 (de) Verfahren zur herstellung von duennen schichten und diese enthaltende mehrschichtige elemente.
ES2422304T3 (es) Método para la producción de partículas
ITMI912944A1 (it) Metodo per eliminare sostanze inquinanti e/o maleodoranti da un flusso gassoso proveniente dall'essicazione di un substrato umido

Legal Events

Date Code Title Description
8364 No opposition during term of opposition